| Product Information |
|
| Registration Number |
DRP-9173-1
|
| Generic Name |
Bortezomib
|
| Brand Name |
Delexomib
|
| Dosage Strength |
3.5 mg
|
| Dosage Form |
Lyophilized Powder for Injection (S.C./I.V.)
|
| Classification |
Prescription Drug (Rx)
|
| Packaging |
Eu. Ph. Type I clear glass vial stoppered with 20 mm grey butyl rubber stopper, sealed with aluminum seal and red flip-off cap (Box of 1's)
|
| Pharmacologic Category |
Antineoplastic Agent (Proteasome Inhibitor)
|
| Manufacturer |
Venus Remedies Ltd
|
| Country of Origin |
India
|
| Trader |
|
| Importer |
Aglobal Care, Inc
|
| Distributor |
Delex Pharma International, Inc.
|
| Application Type |
CLIDP Conversion
|
| Issuance Date |
19 May 2023
|
| Expiry Date |
25 September 2025
|